EPOCH Trial to Explore Ovarian, Uterine Carcinosarcoma Therapies
Walter and Eliza Hall Institute
International clinical trial exploring treatment combinations for rare and aggressive cancers in women launched in Australia
Stable and compatible with a wide variety of HLA allotypes, pMHC-I molecules are a versatile immunotherapy tool